Literature DB >> 31449330

Novel two-phase sampling designs for studying binary outcomes.

Le Wang1,2, Matthew L Williams3, Yong Chen1, Jinbo Chen1.   

Abstract

In biomedical cohort studies for assessing the association between an outcome variable and a set of covariates, usually, some covariates can only be measured on a subgroup of study subjects. An important design question is-which subjects to select into the subgroup to increase statistical efficiency. When the outcome is binary, one may adopt a case-control sampling design or a balanced case-control design where cases and controls are further matched on a small number of complete discrete covariates. While the latter achieves success in estimating odds ratio (OR) parameters for the matching covariates, similar two-phase design options have not been explored for the remaining covariates, especially the incompletely collected ones. This is of great importance in studies where the covariates of interest cannot be completely collected. To this end, assuming that an external model is available to relate the outcome and complete covariates, we propose a novel sampling scheme that oversamples cases and controls with worse goodness-of-fit based on the external model and further matches them on complete covariates similarly to the balanced design. We develop a pseudolikelihood method for estimating OR parameters. Through simulation studies and explorations in a real-cohort study, we find that our design generally leads to reduced asymptotic variances of the OR estimates and the reduction for the matching covariates is comparable to that of the balanced design.
© 2019 The International Biometric Society.

Entities:  

Keywords:  goodness-of-fit; odds ratio estimation; pseudolikelihood; relative efficiency; two-phase design

Year:  2019        PMID: 31449330      PMCID: PMC7042058          DOI: 10.1111/biom.13140

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  12 in total

1.  Design of validation studies for estimating the odds ratio of exposure-disease relationships when exposure is misclassified.

Authors:  C A Holcroft; D Spiegelman
Journal:  Biometrics       Date:  1999-12       Impact factor: 2.571

2.  Optimal design and efficiency of two-phase case-control studies with error-prone and error-free exposure measures.

Authors:  R McNamee
Journal:  Biostatistics       Date:  2005-04-28       Impact factor: 5.899

3.  Optimal sampling strategies for two-stage studies.

Authors:  M Reilly
Journal:  Am J Epidemiol       Date:  1996-01-01       Impact factor: 4.897

4.  A two stage design for the study of the relationship between a rare exposure and a rare disease.

Authors:  J E White
Journal:  Am J Epidemiol       Date:  1982-01       Impact factor: 4.897

5.  osDesign: An R Package for the Analysis, Evaluation, and Design of Two-Phase and Case-Control Studies.

Authors:  Sebastien Haneuse; Takumi Saegusa; Thomas Lumley
Journal:  J Stat Softw       Date:  2011-08       Impact factor: 6.440

6.  LOCAL CASE-CONTROL SAMPLING: EFFICIENT SUBSAMPLING IN IMBALANCED DATA SETS.

Authors:  William Fithian; Trevor Hastie
Journal:  Ann Stat       Date:  2014-10-01       Impact factor: 4.028

7.  Constrained Maximum Likelihood Estimation for Model Calibration Using Summary-level Information from External Big Data Sources.

Authors:  Nilanjan Chatterjee; Yi-Hau Chen; Paige Maas; Raymond J Carroll
Journal:  J Am Stat Assoc       Date:  2016-05-05       Impact factor: 5.033

Review 8.  Economic burden of heart failure in the elderly.

Authors:  Lawrence Liao; Larry A Allen; David J Whellan
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

9.  Efficient Semiparametric Inference Under Two-Phase Sampling, With Applications to Genetic Association Studies.

Authors:  Ran Tao; Donglin Zeng; Dan-Yu Lin
Journal:  J Am Stat Assoc       Date:  2017-02-28       Impact factor: 5.033

10.  Flexible Two-Phase studies for rare exposures: Feasibility, planning and efficiency issues of a new variant.

Authors:  Pascal Wild; Nadine Andrieu; Alisa M Goldstein; Walter Schill
Journal:  Epidemiol Perspect Innov       Date:  2008-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.